Prognostic significance of biologic markers in node-negative breast cancer patients: a prospective study Annalisa VolpiFranca De PaolaDino Amadori OriginalPaper Pages: 181 - 192
Apolipoprotein E polymorphism and breast carcinoma: correlation with cell proliferation indices and clinical outcome E ZunarelliJAR NicollGP Trentini OriginalPaper Pages: 193 - 198
Effects of Bcl-2 modulation with G3139 antisense oligonucleotide on human breast cancer cells are independent of inherent Bcl-2 protein expression Kim N. ChiAnne E. WallisLawrence D. Mayer OriginalPaper Pages: 199 - 212
Unique features of breast cancer in Taiwan Skye Hongiun ChengMei-Hua TsouAndrew T. Huang OriginalPaper Pages: 213 - 223
Serum lipid levels during and after adjuvant toremifene or tamoxifen therapy for breast cancer Heikki JoensuuKaija HolliRitva Valavaara OriginalPaper Pages: 225 - 234
Treatment of advanced, refractory breast cancer with alternating docetaxel and epirubicin/cyclophosphamide plus human granulocyte colony-stimulating factor Werner KwasnyGabriela KornekWerner Scheithauer OriginalPaper Pages: 235 - 241
Biphasic effect of medroxyprogesterone-acetate (MPA) treatment on proliferation and cyclin D1 gene transcription in T47D breast cancer cells Imke ThunekeHeinrich M. SchulteAna-Maria Bamberger OriginalPaper Pages: 243 - 248
Treatment with the pure antiestrogen faslodex (ICI 182780) induces tumor necrosis factor receptor 1 (TNFR1) expression in MCF-7 breast cancer cells Kai SmolnikarStefanie LöffekPatrick Diel OriginalPaper Pages: 249 - 259